T. Rowe Price Associates’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-48,900
| Closed | -$74K | – | 3004 |
|
|
2023
Q1 | $74K | Hold |
48,900
| – | – | ﹤0.01% | 2737 |
|
|
2022
Q4 | $49K | Buy |
48,900
+14,700
| +43% | +$14.7K | ﹤0.01% | 2813 |
|
|
2022
Q3 | $62K | Hold |
34,200
| – | – | ﹤0.01% | 2802 |
|
|
2022
Q2 | $99K | Sell |
34,200
-2,581
| -7% | -$7.47K | ﹤0.01% | 2751 |
|
|
2022
Q1 | $102K | Buy |
36,781
+500
| +1% | +$1.39K | ﹤0.01% | 2835 |
|
|
2021
Q4 | $169K | Buy |
+36,281
| New | +$169K | ﹤0.01% | 2792 |
|